Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Herpes Zoster 2Spondylitis, Ankylosing 1Psoriasis 1Osteosarcoma 1Neuroblastoma 1Lung Neoplasms 1Crohn Disease 1Chickenpox 1Arthritis, Rheumatoid 1Arthritis, Psoriatic 1Arthritis 1

Interventions

Infliximab 5Certolizumab Pegol 5Adalimumab 3Nivolumab 2MEDI2070 2Educational Status 2CT-P13 2vedolizumab 1secukinumab 1golimumab 1cabozantinib 1Vitamin E 1Vaccines 1Ustekinumab 1Sutures 1Surveys and Questionnaires 1Surgical Instruments 1Standard of Care 1Specimen Handling 1Soybean Oil 1Saline Solution 1Ringer's Lactate 1Proctocolectomy, Restorative 1Practice Guidelines as Topic 1Pneumococcal Vaccines 1Platinum Compounds 1Photoplethysmography 1Phlebotomy 1Papillomavirus Vaccines 1Methoxsalen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Crohn Disease × Herpes Zoster Vaccine × Clear all
NCT02538341 2021-11-23

Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)

University of Alabama at Birmingham

Phase 2 Completed
617 enrolled 17 charts

Arthritis, Arthritis, Rheumatoid, Crohn Disease, Psoriasis, Spondylitis, Ankylosing, Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡